Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	33.05	29.27	23.33	17.03	13.38	13.39
Revenue	33.05	29.27	23.33	17.03	13.38	13.39
Revenue Growth (YoY)	26.59%	25.47%	37.00%	27.26%	-0.12%	4.51%
Cost of Revenue	11	10.38	6.5	2.63	2.29	2.24
Gross Profit	22.05	18.89	16.83	14.39	11.09	11.15
Selling, General & Admin	20.85	19.63	16.8	21.87	17.4	13.21
Research & Development	3.17	3.24	3.97	-	-	-
Other Operating Expenses	5.1	5	5.03	2.01	1.58	1.39
Operating Expenses	29.12	27.87	25.8	26.17	20.79	16.12
Operating Income	-7.07	-8.99	-8.97	-11.78	-9.7	-4.97
Interest Expense	-0.18	-0.16	-0.07	-0.05	-0.06	-0.07
Interest & Investment Income	0.09	0.08	0.12	0.1	0.03	0.24
Currency Exchange Gain (Loss)	-	-	-	0.14	-0.05	-0.48
Other Non Operating Income (Expenses)	0.14	-	0.13	0.63	0.54	0.03
EBT Excluding Unusual Items	-7.03	-9.06	-8.79	-10.96	-9.24	-5.25
Asset Writedown	-	-	-	-6.04	-	-
Other Unusual Items	-	-	-	-	1.42	-
Pretax Income	-7.03	-9.06	-8.79	-17	-7.82	-5.25
Income Tax Expense	-	-	-	-1.71	-0.32	-0.89
Earnings From Continuing Operations	-7.03	-9.06	-8.79	-15.29	-7.5	-4.36
Net Income	-7.03	-9.06	-8.79	-15.29	-7.5	-4.36
Net Income to Common	-7.03	-9.06	-8.79	-15.29	-7.5	-4.36
Shares Outstanding (Basic)	275	247	204	156	145	144
Shares Outstanding (Diluted)	275	247	204	156	145	144
Shares Change (YoY)	23.07%	21.16%	30.89%	7.83%	0.69%	0.03%
EPS (Basic)	-0.03	-0.04	-0.04	-0.10	-0.05	-0.03
EPS (Diluted)	-0.03	-0.04	-0.04	-0.10	-0.05	-0.03
Free Cash Flow	-5.21	-6.45	-8.07	-7.09	-4.85	-13.53
Free Cash Flow Per Share	-0.02	-0.03	-0.04	-0.04	-0.03	-0.09
Gross Margin	66.71%	64.54%	72.15%	84.55%	82.89%	83.25%
Operating Margin	-21.40%	-30.70%	-38.47%	-69.19%	-72.50%	-37.07%
Profit Margin	-21.27%	-30.95%	-37.69%	-89.83%	-56.03%	-32.52%
Free Cash Flow Margin	-15.77%	-22.03%	-34.59%	-41.63%	-36.27%	-100.99%
EBITDA	-4.88	-6.72	-5.98	-9.48	-7.89	-3.45
EBITDA Margin	-14.77%	-22.97%	-25.66%	-55.69%	-58.96%	-25.76%
D&A For EBITDA	2.19	2.26	2.99	2.3	1.81	1.52
EBIT	-7.07	-8.99	-8.97	-11.78	-9.7	-4.97
EBIT Margin	-21.40%	-30.70%	-38.47%	-69.19%	-72.50%	-37.07%
Advertising Expenses	-	-	-	3.2	1.78	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.